• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Syngene International Ltd.
    20 Mar 2025
    634.50
    -0.16%
    Syngene shares dip despite completing first US biologics site acquisition
    Business Line
    The new site will increase Syngene's total single-use bioreactor capacity to 50,000L for large molecule discovery, development, and manufacturing services
    Copy LinkShare onShare on Share on Share on
    Syngene International Ltd. is trading below all available SMAs
    logo
    Kilitch Drugs(I) Ltd.
    19 Mar 2025
    High Gain High Volume
    372.15
    7.45%
    This small-cap pharma firm is eyeing a pie of the growing weight-loss drug market
    This small-cap pharma firm is eyeing a pie of the growing weight-loss drug market
    Business Today
    Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is expanding its manufacturing capacity with a new facility in Khopoli, Maharashtra
    Copy LinkShare onShare on Share on Share on
    Kilitch Drugs(I) Ltd. is trading below its 50 day SMA of 388.7
    logo
    Bajaj Healthcare Ltd.
    19 Mar 2025
    486.10
    0.42%
    Bajaj Healthcare shares gain 10%, hits all time high in trade; here's why
    Business Standard
    Cenobamate is an advanced anti-seizure medication used for the treatment of partial-onset seizures in adults
    Copy LinkShare onShare on Share on Share on
    Bajaj Healthcare Ltd. is trading below its 100 day SMA of 491.0
    logo
    Marksans Pharma Ltd.
    19 Mar 2025
    164.06
    -1.48%
    Marksans Pharma up 3% as arm secures marketing authorisation for Baclofen
    Business Standard
    The northward move in Marksans Pharma came after the company's wholly-owned subsidiary, Relonchem, received Marketing Authorisation for the product Baclofen 10 mg Tablets from UK MHRA
    Copy LinkShare onShare on Share on Share on
    Marksans Pharma Ltd. is trading below all available SMAs
    logo
    Strides Pharma Science Ltd.
    19 Mar 2025
    834.10
    0.21%
    Strides Pharma Science share price gains 3% on demerger news; details here
    Business Standard
    The proposed structure, the company said, envisages the NewCo to be a WOS of Strides and there will not be any impact on Strides, financially or otherwise, arising out of the proposed restructuring
    Copy LinkShare onShare on Share on Share on
    Strides Pharma Science Ltd. has gained 33.85% in the last 6 Months
    logo
    Cipla Ltd.
    18 Mar 2025
    1513.10
    -0.30%
    Cipla Secures Exclusive Licensing For Innovative Ophthalmic Solution
    Cipla Secures Exclusive Licensing For Innovative Ophthalmic Solution
    NDTV Profit
    Under the agreement, Cipla gains exclusive rights to market this innovative treatment for post-operative inflammation and pain.
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. has an average target of 1702.60 from 10 brokers.
    logo
    Morepen Laboratories Ltd.
    18 Mar 2025
    48.73
    -1.02%
    Morepen Labs shares skyrocket 12% on rolling out 'Empamore'; details here
    Business Standard
    The uptick in the Morepen Labs share came after the company announced that it has rolled out 'Empamore.'
    Copy LinkShare onShare on Share on Share on
    Morepen Laboratories Ltd. has lost -25.44% in the last 3 Months
    logo
    Akums Drugs & Pharmaceuticals Ltd.
    18 Mar 2025
    441.30
    -1.10%
    'Buy' Akums Drugs And Pharma Maintains ICICI Securities, Sees 39% Upside Here's Why
    'Buy' Akums Drugs And Pharma Maintains ICICI Securities, Sees 39% Upside Here's Why
    NDTV Profit
    ICICI Securities retains Buy with an unchanged target price of Rs 710, valuing the company at 23x FY27E earnings.
    Copy LinkShare onShare on Share on Share on
    Akums Drugs & Pharmaceuticals Ltd. has lost -47.25% in the last 1 Year
    logo
    AstraZeneca Pharma India Ltd.
    17 Mar 2025
    9414.50
    0.89%
    AstraZeneca to buy EsoBiotec for up to $1 billion
    Business Line
    EsoBiotec's platform has the potential to transform cell therapy, according to AstraZeneca, by empowering the immune system to attack cancers
    Copy LinkShare onShare on Share on Share on
    Number of MF schemes increased from 53 to 60 in Jun 2025 qtr.
    logo
    Sai Life Science Ltd.
    17 Mar 2025
    866.25
    -1.85%
    Sai Life Sciences Gets 'Hold' As Jefferies Initiates Coverage, Flags High Valuation
    Sai Life Sciences Gets 'Hold' As Jefferies Initiates Coverage, Flags High Valuation
    NDTV Profit
    Jefferies expects Sai Life Sciences to provide 15% revenue CAGR of Rs 800 crore over financial years 2025 to 2027.
    Copy LinkShare onShare on Share on Share on
    Promoters unpledged 2.66% of shares in last quarter. Total pledge stands at 0.01% of promoter holdings
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Greenleaf Envirotech
    • DSM Fresh Foods
    • Tata Capital
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)